Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Is AstraZeneca Still One Of The Strongest Long-Term Growth Stocks In Europe?

AstraZeneca gained 1.80% on 19 June 2026 as investors rotated into high-quality defensive growth companies amid ongoing geopolitical uncertainty and global market volatility.

Ankur Sharma | 19 June 2026

Is AI-Powered Drug Discovery, Healthcare Innovation and Biotechnology M&A Driving the Surge?

Biotech Growth Trust PLC advanced approximately 1.79% on 18 June 2026 as investors increasingly returned to biotechnology and healthcare innovation investments amid improving sentiment across the global life sciences sector.

Ankur Sharma | 19 June 2026

Could AstraZeneca’s Research Pipeline Unlock New Opportunities?

Over the past decade, AstraZeneca has transformed itself into a research-driven pharmaceutical powerhouse with a diversified portfolio and a robust development pipeline. Its ability to consistently launch innovative therapies and expand into new treatment areas has made it a prominent player in the global …

Ishan Mudgal | 18 June 2026

Does GSK’s Latest Approval Change the Investment Case?

Pharmaceutical giant GSK (LSE:GSK) has returned to the spotlight after news relating to a regulatory approval drew fresh attention to its antibiotic pipeline. As one of the world's leading drugmakers, with a portfolio spanning vaccines, specialty medicines and a long-standing presence in infectious disease, …

Ankur Sharma | 18 June 2026

Could Advanced Medical Solutions Benefit from Growing Medtech Interest?

Advanced Medical Solutions Group (LSE:AMS) has moved into the spotlight after a disclosure put the UK medical technology stock baLck on investors' radar. For those who follow healthcare and medtech shares, dealing disclosures and merger-and-acquisition filings are the kind of market-activity events that can …

Ankur Sharma | 18 June 2026

Can Biotechnology Manufacturing Support Future Growth?

Oxford BioMedica plc (LSE:OXB) is trading higher today as investors continue recognising the company's strategic position within the rapidly growing cell and gene therapy industry. The biotechnology sector has experienced improving sentiment in recent weeks, while demand for specialised manufacturing services remains strong as …

Divya Sood | 18 June 2026

Can AI Drug Discovery Drive Further Gains for Biotechnology Investors?

Biotech Growth Trust benefited from improving investor sentiment toward healthcare and biotechnology investments.

Ankur Sharma | 18 June 2026

Is LSE:AZN - AstraZeneca PLC Benefiting From Strong Oncology Growth and Global Healthcare Demand?

Why Did LSE:AZN - AstraZeneca PLC Rise 0.64% on 16 June 2026?LSE:AZN - AstraZeneca PLC gained approximately0.64% on 16 June 2026as investors rotated into high-quality healthcare stocks amid geopolitical uncertainty, economic concerns and ongoing demand for defensive sectors capable of delivering consistent earnings growth.The …

Ankur Sharma | 17 June 2026

Is LSE:RKT - Reckitt Benckiser Group plc Becoming a Safe-Haven FTSE 100 Stock Amid Global Market Volatility?

Why Did LSE:RKT - Reckitt Benckiser Group plc Rise 1.17% on 16 June 2026?LSE:RKT - Reckitt Benckiser Group plc gained approximately1.17% on 16 June 2026as investors increasingly shifted capital toward defensive sectors capable of delivering stable earnings and resilient cash flows amid rising geopolitical …

Ankur Sharma | 17 June 2026

Could LSE:CRDA - Croda International Plc Be Preparing for a Stronger Recovery After Its 1.32% Gain on 16 June 2026?

LSE:CRDA - Croda International Plc rose1.32% on 16 June 2026, outperforming several peers as investors continued rotating into high-quality specialty chemicals and life sciences companies positioned to benefit from improving global demand conditions and long-term innovation trends.

Ankur Sharma | 17 June 2026
Support

Hi! How can we help you today?

Loading…